[The treatment of chronic ischemic heart disease with acidum acetylsalicylicum in older patients (author's transl)].
During a double-blind study in 38 older patients with ischemic heart disease (that means with angina pectoris stabilis according WHO), who got for 48 months 1.500 mg Acidum acetylosalicylicum daily (three times a day 500 mg p. o.) in the research group (I) occurred significantly seldom coronary deaths, no lethal heart infarcts, furthermore the cholesterin level in the group I significantly sank and also heavy collateral effects during the ambulant long term treatment so far have not been observed. According to our opinion the gastrointestinal collateral effects can almost completely avoided, so that the medicine appears to be well endured and a suitable aggregation prevention for long term prophylaxis of thrombotic sickness.
D000368:Aged; D000787:Angina Pectoris / Q000188:drug therapy; D001241:Aspirin / Q000627:therapeutic use*; D002784:Cholesterol / Q000097:blood; D003327:Coronary Disease / Q000188:drug therapy*; D004311:Double-Blind Method; D006801:Humans; D008297:Male; D012306:Risk
D002784:Cholesterol; D001241:Aspirin
Die Behandlung der chronisch-ischämischen Herzkrankheit mit einem Azetylsalizylsäurepräparat bei älteren Patienten.